Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Psychopharmacology
|
September 21, 2007
Evaluation of cannabinoid agonists using punished responding and midazolam discrimination procedures in squirrel monkeys
Marcus S Delatte, Carol A Paronis
Experimental and Clinical Psychopharmacology
|
December 25, 2002
Effects of triazolam, 8-OH-DPAT, and buspirone on repeated acquisition in squirrel monkeys
Peter J Winsauer, Marcus S Delatte, Michael W Stevenson, et al.
Journal of Pharmacological and Toxicological Methods
|
March 20, 2016
EEG in non-clinical drug safety assessments: Current and emerging considerations
Simon Authier, Marcus S Delatte, Mary-Jeanne Kallman, et al.
Toxicologic Pathology
|
December 5, 2024
The Role of Neuropathology Evaluation in the Nonclinical Assessment of Seizure Liability
Katie Sokolowski, Judy Liu, Marcus S Delatte, et al.
Physiology & Behavior
|
December 14, 2007
Some effects of CB1 antagonists with inverse agonist and neutral biochemical properties
Jack Bergman, Marcus S Delatte, Carol A Paronis, et al.
Pharmacological Reviews
|
June 7, 2024
The Development of Cannabinoids as Therapeutic Agents in the United States
Conor H Murray, Brenda M Gannon, Peter J Winsauer, et al.
Behavioural Pharmacology
|
January 31, 2009
Relative potency and effectiveness of flunitrazepam, ethanol, and beta-CCE for disrupting the acquisition and retention of response sequences in rats
Stuart T Leonard, Lisa R Gerak, Marcus S Delatte, et al.
International Journal of Toxicology
|
January 7, 2025
Identifying and Understanding Seizure Liability in Drug Development
Katie Sokolowski, Laura Erwin, Judy Liu, et al.
Psychopharmacology
|
February 2, 2002
Effects of fenfluramine, m-CPP and triazolam on repeated-acquisition in squirrel monkeys before and after neurotoxic MDMA administration
Peter J Winsauer, Una D McCann, J Yuan, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 5, 2013
Cannabinoid discrimination and antagonism by CB(1) neutral and inverse agonist antagonists
Brian D Kangas, Marcus S Delatte, V Kiran Vemuri, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Psychopharmacology
|
September 21, 2007
Evaluation of cannabinoid agonists using punished responding and midazolam discrimination procedures in squirrel monkeys
Marcus S Delatte, Carol A Paronis
Experimental and Clinical Psychopharmacology
|
December 25, 2002
Effects of triazolam, 8-OH-DPAT, and buspirone on repeated acquisition in squirrel monkeys
Peter J Winsauer, Marcus S Delatte, Michael W Stevenson, et al.
Journal of Pharmacological and Toxicological Methods
|
March 20, 2016
EEG in non-clinical drug safety assessments: Current and emerging considerations
Simon Authier, Marcus S Delatte, Mary-Jeanne Kallman, et al.
Toxicologic Pathology
|
December 5, 2024
The Role of Neuropathology Evaluation in the Nonclinical Assessment of Seizure Liability
Katie Sokolowski, Judy Liu, Marcus S Delatte, et al.
Physiology & Behavior
|
December 14, 2007
Some effects of CB1 antagonists with inverse agonist and neutral biochemical properties
Jack Bergman, Marcus S Delatte, Carol A Paronis, et al.
Pharmacological Reviews
|
June 7, 2024
The Development of Cannabinoids as Therapeutic Agents in the United States
Conor H Murray, Brenda M Gannon, Peter J Winsauer, et al.
Behavioural Pharmacology
|
January 31, 2009
Relative potency and effectiveness of flunitrazepam, ethanol, and beta-CCE for disrupting the acquisition and retention of response sequences in rats
Stuart T Leonard, Lisa R Gerak, Marcus S Delatte, et al.
International Journal of Toxicology
|
January 7, 2025
Identifying and Understanding Seizure Liability in Drug Development
Katie Sokolowski, Laura Erwin, Judy Liu, et al.
Psychopharmacology
|
February 2, 2002
Effects of fenfluramine, m-CPP and triazolam on repeated-acquisition in squirrel monkeys before and after neurotoxic MDMA administration
Peter J Winsauer, Una D McCann, J Yuan, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 5, 2013
Cannabinoid discrimination and antagonism by CB(1) neutral and inverse agonist antagonists
Brian D Kangas, Marcus S Delatte, V Kiran Vemuri, et al.
Page
of 2